FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

1204319004: Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
4953316013 Retinol (as retinol palmitate) 50000 unit/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
4953317016 Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Is a Medicinal product (product) true Inferred relationship Some
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Has manufactured dose form Solution for injection true Inferred relationship Some
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Has basis of strength substance (attribute) Retinol true Inferred relationship Some 1
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Has concentration strength denominator unit mL true Inferred relationship Some 1
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Has concentration strength numerator unit Unit true Inferred relationship Some 1
Retinol (as retinol palmitate) 50000 unit/mL solution for injection Has precise active ingredient Retinol palmitate (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start